Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis

Inclusion Criteria: * Male or female aged ≥18 years. * Body Mass Index (BMI) \<22.9 kg/m². * Newly diagnosed pulmonary tuberculosis (TB). * Diagnosis confirmed by bacteriological and/or clinical-radiological findings. * Have not received anti-tuberculosis treatment, or have received treatment for less than two weeks. * Willing to participate in the study by providing written informed consent and signing the Informed Consent Form. Exclusion Criteria: * Pregnant or breastfeeding women. * Individuals who are overweight or obese. * Individuals with comorbidities such as diabetes mellitus, HIV, impaired kidney function, or impaired liver function. * Patients with drug-resistant tuberculosis, including MDR-TB or XDR-TB, or patients who previously failed an anti-tuberculosis treatment regimen. * Patients with extrapulmonary tuberculosis. * Patients who have consumed snakehead fish supplements, curcuma supplements, or high-dose multivitamin supplements within the previous two weeks. * Patients with a history of allergy to fish or turmeric-derived products. Patients with swallowing disorders or gastrointestinal diseases that may affect supplement absorption. * Patients who are uncooperative or discontinue treatment before completing the study.